Literature DB >> 23029874

Exogenous surfactant replacement: how to deliver it?

Paolo Biban1, Lorenza Chini, Paolo Bonetti, Francesco Sacco, Federico Zaglia, Pierantonio Santuz.   

Abstract

Exogenous surfactant is a therapeutic option for newborns, children and adults with acute respiratory distress disorders. Although tracheal instillation is still reputed as the classical method of surfactant delivery, alternative techniques have been investigated. Surfactant administration by using thin intra-tracheal catheters, bronchoscopy, laryngeal mask airway, or nebulisation, although variably effective, appear to be less invasive when compared to tracheal intubation. However, further research is still needed to better clarify this matter. (www.actabiomedica.it).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23029874

Source DB:  PubMed          Journal:  Acta Biomed        ISSN: 0392-4203


  3 in total

1.  New perpective for an old problem: extracellular vesicle based management of respiratory distress syndrome.

Authors:  Defne Engur; Abdullah Kumral
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

Review 2.  Surfactants in Acute Respiratory Distress Syndrome in Infants and Children: Past, Present and Future.

Authors:  Angela Amigoni; Andrea Pettenazzo; Valentina Stritoni; Maria Circelli
Journal:  Clin Drug Investig       Date:  2017-08       Impact factor: 2.859

3.  Trial of aerosolised surfactant for preterm infants with respiratory distress syndrome.

Authors:  Luke Jardine; Kei Lui; Helen G Liley; Timothy Schindler; James Fink; Jeanette Asselin; David Durand
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2021-06-10       Impact factor: 5.747

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.